← Evidence map

ArticleCell death & disease2023

Vemurafenib inhibits necroptosis in normal and pathological conditions as a RIPK1 antagonist.

Mayu Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2023
2024
2025
2026
2027
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37620300